Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
The Globe and Mail
18m
Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to treat type 2 diabetes. Novo's drugs Ozempic and Wegovy are household names ...
The Globe and Mail
18m
Is Viking Therapeutics a Buy on the Dip?
You'll probably recognize their names after seeing them in the news or across social media: Ozempic and Wegovy (made by Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Trump sweeps swing states
Delaney wins US House seat
US woman killed in Hungary
Resigns after election losses
Judith Jamison dies
Man charged with arson
FTX sues Scaramucci
NASCAR legend Allison dies
Philippines new maritime laws
Gabriel breaks NCAA record
UKR drones strike Moscow
UN nuclear head to visit Iran
Suit over Philly ballots
Ex-Blazers broadcaster dies
S&P 500 breaks 6,000 level
US energy revenue 2024
Leads Grammy nominations
Global food prices rise
IL weapons ban blocked
Qatar halts Gaza mediation
Wins Nevada Senate race
‘Candyman' star dies
Seattle stabbing spree ends
Consumer sentiment rises
Hits $80K for the first time
Asked to be US trade chief
Rockefeller tree arrives
Gauff wins WTA Finals
Wins 1st NASCAR Xfinity title
Launches bid to chair NRSC
Ranger dies in wildfire
Feedback